Art

J-GLOBAL ID：202402221455786434   Reference number：24A0362281

Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease

生物学的治療の異なる系統にわたるStill病患者におけるカナキヌマブの有効性:Still病に対する国際AIDAネットワーク登録からの実生活データ【JST・京大機械翻訳】

Author (76)： Vitale Antonio (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Vitale Antonio (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Caggiano Valeria (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Caggiano Valeria (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Sfikakis Petros P. (Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece) ,  Dagna Lorenzo (Division of Immunology, Transplants and Infectious Diseases, Universita Vita-Salute San Raffaele, Milan, Italy) ,  Dagna Lorenzo (Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy) ,  Lopalco Giuseppe (Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy) ,  Ragab Gaafar (Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt) ,  Ragab Gaafar (Faculty of Medicine, Newgiza University, 6th of October City, Egypt) ,  La Torre Francesco (Department of Pediatrics, Pediatric Rheumatology Center, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy) ,  Almaghlouth Ibrahim A. (Rheumatology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia) ,  Almaghlouth Ibrahim A. (College of Medicine Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia) ,  Maggio Maria Cristina (University Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) ”G. D’Alessandro”, University of Palermo, Palermo, Italy) ,  Sota Jurgen (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Sota Jurgen (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Tufan Abdurrahman (Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital, Ankara, Tuerkiye) ,  Hinojosa-Azaola Andrea (Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico) ,  Iannone Florenzo (Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy) ,  Loconte Roberta (Department of Pediatrics, Pediatric Rheumatology Center, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy) ,  Laskari Katerina (Joint Academic Rheumatology Program, The First Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece) ,  Direskeneli Haner (Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Tuerkiye) ,  Ruscitti Piero (Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy) ,  Morrone Maria (Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy) ,  Mayrink Giardini Henrique A. (Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas, Universidade de Sao Paulo, Sao Paulo, Brazil) ,  Panagiotopoulos Alexandros (Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece) ,  Di Cola Ilenia (Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy) ,  Martin-Nares Eduardo (Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico) ,  Monti Sara (Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy) ,  Monti Sara (Department of Internal Medicine and Therapeutics, Universita di Pavia, Pavia, Italy) ,  De Stefano Ludovico (Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy) ,  De Stefano Ludovico (Department of Internal Medicine and Therapeutics, Universita di Pavia, Pavia, Italy) ,  Kardas Riza Can (Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital, Ankara, Tuerkiye) ,  Duran Rahime (Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital, Ankara, Tuerkiye) ,  Campochiaro Corrado (Division of Immunology, Transplants and Infectious Diseases, Universita Vita-Salute San Raffaele, Milan, Italy) ,  Campochiaro Corrado (Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy) ,  Tomelleri Alessandro (Division of Immunology, Transplants and Infectious Diseases, Universita Vita-Salute San Raffaele, Milan, Italy) ,  Tomelleri Alessandro (Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy) ,  Alabdulkareem Abdulaziz Mohammed (Rheumatology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia) ,  Gaggiano Carla (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Gaggiano Carla (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Tarsia Maria (, Department of Molecular Medicine and DevelopmentClinical Pediatrics, University of Siena, Siena, Italy) ,  Tarsia Maria (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Bartoloni Elena (Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy) ,  Romeo Mery (Pediatric Nephrology and Rheumatology Unit, Azienda Ospedaliera Universitaria (AOU), ”G. Martino”, Messina, Italy) ,  Hussein Mohamed A. (Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt) ,  Laymouna Ahmed Hatem (Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt) ,  Parente de Brito Antonelli Isabele (Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas, Universidade de Sao Paulo, Sao Paulo, Brazil) ,  Dagostin Marilia Ambiel (Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas, Universidade de Sao Paulo, Sao Paulo, Brazil) ,  Fotis Lampros (Department of Pediatrics, Attikon General Hospital, National and Kapodistrian University of Athens, Zografou, Greece) ,  Bindoli Sara (Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy) ,  Navarini Luca (Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, Rome, Italy) ,  Navarini Luca (Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, School of Medicine, University of Rome “Campus Biomedico”, Rome, Italy) ,  Alibaz-Oner Fatma (Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Tuerkiye) ,  Sevik Gizem (Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Tuerkiye) ,  Frassi Micol (Spedali Civili and Department of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology, University of Brescia, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Brescia, Italy) ,  Ciccia Francesco (Department of Precision Medicine, University of Campania ”Luigi Vanvitelli”, Naples, Italy) ,  Iacono Daniela (Department of Precision Medicine, University of Campania ”Luigi Vanvitelli”, Naples, Italy) ,  Crisafulli Francesca (Spedali Civili and Department of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology, University of Brescia, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Brescia, Italy) ,  Portincasa Piero (Clinica Medica ”A. Murri”, Division of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Bari, Italy) ,  Jaber Nour (Clinica Medica ”A. Murri”, Division of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Bari, Italy) ,  Kawakami-Campos Perla Ayumi (Department of Ophthalmology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico) ,  Wiesik-Szewczyk Ewa (Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, National Research Institute, Warsaw, Poland) ,  Iagnocco Annamaria (Academic Rheumatology Centre, Dipartimento Scienze Cliniche e Biologiche, Universita degli Studi di Torino, Torino, Italy) ,  Simonini Gabriele (NEUROFARBA Department, Rheumatology Unit, Meyer Children’s Hospital IRCCS, University of Florence, Florence, Italy) ,  Sfriso Paolo (Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy) ,  Balistreri Alberto (Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena, Siena, Italy) ,  Giacomelli Roberto (Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, Rome, Italy) ,  Giacomelli Roberto (Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, School of Medicine, University of Rome “Campus Biomedico”, Rome, Italy) ,  Conti Giovanni (Pediatric Nephrology and Rheumatology Unit, Azienda Ospedaliera Universitaria (AOU), ”G. Martino”, Messina, Italy) ,  Frediani Bruno (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Frediani Bruno (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Fabiani Claudia (Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy) ,  Fabiani Claudia (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy) ,  Cantarini Luca (Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behcet’s Disease Clinic, University of Siena, Siena, Italy) ,  Cantarini Luca (Azienda Ospedaliero-Universitaria Senese, European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy)
Material： Frontiers in Medicine (Web)
Volume： 10  Page： 1256243  Publication year： 2023 
JST Material Number： U7079A  ISSN： 2296-858X  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Introduction: The effectivenes...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=24A0362281&from=J-GLOBAL&jstjournalNo=U7079A") }}

Thesaurus term： *network ,  allergic reaction ,  *biological preparation ,  woman ,  man ,  glucocorticoid ,  effectiveness ,  *monoclonal antibody ,  recurrence ,  *Still's disease ,  *molecular targeting drug ,  Individualized Medicine
Semi thesaurus term： 希少疾患 ,  治療失敗 ,  生物学的治療 ,  長期治療 ,  自己炎症性症候群 ,  *カナキヌマブ , 【Automatic Indexing@JST】

Author keywords (5)： AOSD ,  AutoInflammatory diseases ,  rare diseases ,  personalized medicine ,  treatment

JST classification (2)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D) ,  Cryptogenic diseases,other diseases in general  (GD07010X)

Reference (27)：

• Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum. (1993) 23:34-46. doi: , PMID: doi: 10.1016/S0049-0172(05)80025-3
• Oommen PT, Strauss T, Baltruschat K, Foeldvari I, Deuter C, Ganser G, et al. Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): new perspectives on interdisciplinary care. Clin Immunol. (2022) 245:109143. doi: , PMID: doi: 10.1016/j.clim.2022.109143
• Vitale A, Caggiano V, Maggio MC, Lopalco G, Emmi G, Sota J, et al. Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry. Front Med (Lausanne). (2022) 9:1071732. doi: , PMID: doi: 10.3389/fmed.2022.1071732
• Ruscitti P, Cipriani P, Liakouli V, Guggino G, Carubbi F, Berardicurti O, et al. Managing adult-onset Still's disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Medicine. (2019) 98:e15123. doi: , PMID: doi: 10.1097/MD.0000000000015123
• De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. (2012) 367:2385-95. doi: doi: 10.1056/NEJMoa1112802

Terms in the title (6)： 生物学的治療 ,  系統 ,  Still病 ,  患者 ,  カナキヌマブ ,  有効性